DEFA14A: Pono Capital Two Amends Non-Redemption Agreement Ahead of SBC Medical Group Merger Vote

Pono Capital Two, Inc. updates its non-redemption agreement to bolster its proposed business combination with SBC Medical Group Holdings Incorporated.

Summary

• Pono Capital Two, Inc. has amended its non-redemption agreement with an unaffiliated investor.
• The investor agreed to purchase between 1,500,000 and 1,700,000 shares of Class A common stock in the open market to support the business combination with SBC Medical Group Holdings Incorporated.
• The aim is to ensure the initial listing application with The Nasdaq Stock Market is approved.
• As of the report date, the investor has acquired 1,512,575 shares at a weighted average price of $11.04 per share.
• Redemption requests have been received for 135,471 shares of Class A common stock by the redemption deadline of August 21, 2024.
• The company believes the Holder's purchase of shares will not impact the likelihood of stockholder approval of the business combination.

Sentiment

Score: 6

Explanation: The sentiment is neutral to slightly positive. While the non-redemption agreement is a positive step to ensure the merger's completion, it also highlights potential concerns about shareholder support and the need for additional measures to secure the deal.

Positives

• The non-redemption agreement aims to increase the likelihood of the business combination closing.
• The investor's share purchases support the company's Nasdaq listing application.
• The company has received redemption requests for only 135,471 shares, which may be considered a positive sign for the merger's approval.

Negatives

• The need for a non-redemption agreement suggests potential challenges in securing sufficient shareholder support for the merger.
• The risk remains that the business combination may not be completed.

Risks

• The business combination may not be completed in a timely manner or at all.
• Conditions to the consummation of the business combination may not be satisfied, including stockholder approval.
• Legal proceedings could be instituted against the parties to the Merger Agreement.
• Redemptions may exceed anticipated levels.
• The company may fail to meet Nasdaq's initial listing standards.
• The announcement or pendency of the business combination could negatively impact SBC's business relationships and operating results.
• Pono and SBC may need to raise additional capital, which may not be available on acceptable terms.
• There is a lack of useful financial information for an accurate estimate of future capital expenditures and future revenue.

Future Outlook

The document contains forward-looking statements regarding the proposed business combination, which are subject to risks and uncertainties. Actual results may differ materially from expectations, and the companies assume no obligation to update these statements.

Management Comments

• The primary purpose of entering into the Non-Redemption Agreement was to help ensure that post-business combination company's initial listing application with The Nasdaq Stock Market is approved, increasing the likelihood that the business combination transaction will close.
• The Company does not believe the Holder's purchase of the shares pursuant to the Non-Redemption Agreement will have any impact on the likelihood that the business combination will be approved by stockholders of the Company.

Industry Context

SPACs often use non-redemption agreements to ensure sufficient capital remains after the merger to meet listing requirements and fund operations. This is a common practice in the SPAC market, especially when facing potential redemptions.

Comparison to Industry Standards

• Non-redemption agreements are a common tool used by SPACs facing potential redemptions, similar to strategies employed by companies like Digital World Acquisition Corp. during their merger process.
• The level of redemptions and the need for such agreements can be compared to other SPAC mergers in the healthcare sector to gauge the relative investor confidence in the deal.

Stakeholder Impact

• Shareholders: The business combination and potential redemptions could impact share value.
• Employees: The merger could lead to changes in the organizational structure and job security.
• Customers and Suppliers: The merger could affect business relationships and contract terms.

Next Steps

• Stockholder vote on the amendment to the Company's Third Amended and Restated Certificate of Incorporation.
• Closing of the business combination with SBC Medical Group Holdings Incorporated.
• Approval of the initial listing application with The Nasdaq Stock Market.

Key Dates

Keywords

business combination, non-redemption agreement, Pono Capital Two, SBC Medical Group, merger, redemption, Nasdaq, stockholder approval